Tag : Antiplatelet

Neurology

Safety and efficacy of dual antiplatelet pretreatment in patients with ischemic stroke treated with IV thrombolysis: A systematic review and meta-analysis

Newsemia
Objective Conflicting data exist on the safety and efficacy of IV thrombolysis (IVT) in patients with acute ischemic stroke (AIS) receiving dual antiplatelet pretreatment (DAPP)....
Latest News

 Subgroup Analysis of TWILIGHT Trial Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Who Underwent PCI Showed BRILINTA Monotherapy Reduced the Risk of Clinically Relevant Bleeding Compared With Dual Antiplatelet Therapy (DAPT)

Newsemia
WILMINGTON, Del.–(BUSINESS WIRE)–New results from a pre-specified subgroup analysis of the TWILIGHT trial showed that BRILINTA (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding...
Cardiology

Antiplatelet therapy in secondary ischemic stroke prevention – a short review.

Newsemia
Related Articles Antiplatelet therapy in secondary ischemic stroke prevention – a short review. Rom J Morphol Embryol. 2019;60(2):383-387 Authors: Florescu C, Mustafa ER, Târtea EA,...
Dentistry

Frequency and Reasons of Dual Antiplatelet Therapy Discontinuation and Switching of P2Y12 Inhibitors in Patients with Acute Coronary Syndrome Treated with Stent Implantation.

Newsemia
Related Articles Frequency and Reasons of Dual Antiplatelet Therapy Discontinuation and Switching of P2Y12 Inhibitors in Patients with Acute Coronary Syndrome Treated with Stent Implantation....
Cardiology

A comparison of anticoagulation, antiplatelet, and placebo treatment for patients with heart failure reduced ejection fraction in sinus rhythm: a systematic review and meta-analysis.

Newsemia
A comparison of anticoagulation, antiplatelet, and placebo treatment for patients with heart failure reduced ejection fraction in sinus rhythm: a systematic review and meta-analysis. Heart...
Cardiology

Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study.

Newsemia
Related Articles Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study. J Thromb Thrombolysis. 2019 Jun 08;: Authors:...
Neurology

Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half

Newsemia
Restarting antiplatelet therapy after intracranial hemorrhage remains controversial, but new evidence suggests aspirin or clopidogrel can significantly reduce recurrent ICH without increased bleeding. Medscape Medical...
Pharma / Biotech

Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab.

Newsemia
Related Articles Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab. Arterioscler Thromb Vasc Biol. 2019 May;39(5):956-964 Authors: Voors-Pette C,...
Neurology

Novel Antiplatelet Agent May Not Increase Bleeding Risk

Newsemia
Initial clinical results suggest that the new agent may be suitable for use with thrombolysis in acute ischemic stroke. Medscape Medical News Source link...
Latest News

Dental extractions for patients on oral antiplatelet: a within-person randomised controlled trial comparing haemostatic plugs, advanced-plateletrich fibrin (A-PRF+) plugs, leukocyte- and platelet-rich fibrin (L-PRF) plugs and suturing alone

Newsemia
Giudice, A; Esposito, M; Bennardo, F; Brancaccio, Y; Buti, J; Fortunato, L; (2019) Dental extractions for patients on oral antiplatelet: a within-person randomised controlled trial...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy